{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T02:42:46Z","timestamp":1792896166326,"version":"4.5.0"},"reference-count":123,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2024,3,5]],"date-time":"2024-03-05T00:00:00Z","timestamp":1709596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,3,5]],"date-time":"2024-03-05T00:00:00Z","timestamp":1709596800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1007\/s00520-024-08388-4","type":"journal-article","created":{"date-parts":[[2024,3,5]],"date-time":"2024-03-05T20:01:41Z","timestamp":1709668901000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Medication-related osteonecrosis of the jaw: evolving research for multimodality medical management"],"prefix":"10.1007","volume":"32","author":[{"given":"Ali","family":"Abdolrahmani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel B.","family":"Epstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Firoozeh","family":"Samim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,3,5]]},"reference":[{"issue":"10","key":"8388_CR1","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1016\/j.joms.2014.04.031","volume":"72","author":"SL Ruggiero","year":"2014","unstructured":"Ruggiero SL et al (2014) American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw\u20132014 update. J Oral Maxillofac Surg 72(10):1938\u20131956","journal-title":"J Oral Maxillofac Surg"},{"issue":"25","key":"8388_CR2","doi-asserted-by":"publisher","first-page":"2270","DOI":"10.1200\/JCO.19.01186","volume":"37","author":"N Yarom","year":"2019","unstructured":"Yarom N et al (2019) Medication-related osteonecrosis of the jaw: MASCC\/ISOO\/ASCO Clinical Practice Guideline. J Clin Oncol 37(25):2270\u20132290","journal-title":"J Clin Oncol"},{"issue":"5","key":"8388_CR3","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1016\/j.joms.2022.02.008","volume":"80","author":"SL Ruggiero","year":"2022","unstructured":"Ruggiero SL et al (2022) American Association of Oral and Maxillofacial Surgeons\u2019 Position Paper on Medication-Related Osteonecrosis of the Jaws-2022 Update. J Oral Maxillofac Surg 80(5):920\u2013943","journal-title":"J Oral Maxillofac Surg"},{"issue":"3","key":"8388_CR4","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.jormas.2019.12.003","volume":"121","author":"J Li","year":"2020","unstructured":"Li J, Wang W (2020) Positive effect of pentoxifylline on medication-related osteonecrosis of the jaw. J Stomatol Oral Maxillofac Surg 121(3):264\u2013267","journal-title":"J Stomatol Oral Maxillofac Surg"},{"issue":"2","key":"8388_CR5","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.mrgentox.2013.07.003","volume":"757","author":"S Polidoro","year":"2013","unstructured":"Polidoro S et al (2013) Effects of bisphosphonate treatment on DNA methylation in osteonecrosis of the jaw. Mutat Res 757(2):104\u2013113","journal-title":"Mutat Res"},{"issue":"5","key":"8388_CR6","doi-asserted-by":"publisher","first-page":"2509","DOI":"10.1007\/s00520-020-05748-8","volume":"29","author":"DA Kizub","year":"2021","unstructured":"Kizub DA et al (2021) Risk factors for bisphosphonate-associated osteonecrosis of the jaw in the prospective randomized trial of adjuvant bisphosphonates for early-stage breast cancer (SWOG 0307). Support Care Cancer 29(5):2509\u20132517","journal-title":"Support Care Cancer"},{"issue":"9","key":"8388_CR7","doi-asserted-by":"publisher","first-page":"7047","DOI":"10.1007\/s00520-022-06982-y","volume":"30","author":"V Fusco","year":"2022","unstructured":"Fusco V, Campisi G, Bedogni A (2022) One changing and challenging scenario: the treatment of cancer patients with bone metastases by bisphosphonates and denosumab, the cost-benefit evaluation of different options, and the risk of medication-related osteonecrosis of the jaw (MRONJ). Support Care Cancer 30(9):7047\u20137051","journal-title":"Support Care Cancer"},{"issue":"9","key":"8388_CR8","doi-asserted-by":"publisher","first-page":"7241","DOI":"10.1007\/s00520-022-07134-y","volume":"30","author":"S Soutome","year":"2022","unstructured":"Soutome S et al (2022) Risk factors for developing medication-related osteonecrosis of the jaw when preserving the tooth that can be a source of infection in cancer patients receiving high-dose antiresorptive agents: a retrospective study. Support Care Cancer 30(9):7241\u20137248","journal-title":"Support Care Cancer"},{"issue":"10","key":"8388_CR9","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1038\/s41416-020-01043-9","volume":"123","author":"YY Li","year":"2020","unstructured":"Li YY et al (2020) Bisphosphonates and risk of cancers: a systematic review and meta-analysis. Br J Cancer 123(10):1570\u20131581","journal-title":"Br J Cancer"},{"issue":"9","key":"8388_CR10","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.4065\/83.9.1032","volume":"83","author":"MT Drake","year":"2008","unstructured":"Drake MT, Clarke BL, Khosla S (2008) Bisphosphonates: mechanism of action and role in clinical practice. Mayo Clin Proc 83(9):1032\u20131045","journal-title":"Mayo Clin Proc"},{"issue":"4","key":"8388_CR11","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.coms.2015.06.001","volume":"27","author":"T Aghaloo","year":"2015","unstructured":"Aghaloo T, Hazboun R, Tetradis S (2015) Pathophysiology of osteonecrosis of the jaws. Oral Maxillofac Surg Clin North Am 27(4):489\u2013496","journal-title":"Oral Maxillofac Surg Clin North Am"},{"key":"8388_CR12","doi-asserted-by":"publisher","first-page":"105792","DOI":"10.1016\/j.archoralbio.2023.105792","volume":"155","author":"D Nogueira","year":"2023","unstructured":"Nogueira D, Caldas IM, Dinis-Oliveira RJ (2023) Bisphosphonates and osteonecrosis of the jaws: clinical and forensic aspects. Arch Oral Biol 155:105792","journal-title":"Arch Oral Biol"},{"issue":"1","key":"8388_CR13","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/s00198-019-05233-x","volume":"31","author":"PD Miller","year":"2020","unstructured":"Miller PD et al (2020) Efficacy and safety of denosumab vs. bisphosphonates in postmenopausal women previously treated with oral bisphosphonates. Osteoporos Int 31(1):181\u2013191","journal-title":"Osteoporos Int"},{"issue":"6 Suppl. 2","key":"8388_CR14","first-page":"37","volume":"34","author":"D De Santis","year":"2020","unstructured":"De Santis D et al (2020) New trends in adjunctive treatment and diagnosis in medication-related osteonecrosis of the jaw: a 10-year review. J Biol Regul Homeost Agents 34(6 Suppl. 2):37\u201348","journal-title":"J Biol Regul Homeost Agents"},{"issue":"12","key":"8388_CR15","doi-asserted-by":"publisher","first-page":"2499","DOI":"10.1016\/j.joms.2021.06.036","volume":"79","author":"E Fa\u00e7anha de Carvalho","year":"2021","unstructured":"Fa\u00e7anha de Carvalho E et al (2021) Cilostazol and tocopherol in the management of medication-related osteonecrosis of the jaw: new insights from a case report. J. Oral Maxillofac. Surg 79(12):2499\u20132506","journal-title":"J. Oral Maxillofac. Surg"},{"issue":"2","key":"8388_CR16","doi-asserted-by":"publisher","first-page":"195","DOI":"10.3390\/antibiotics10020195","volume":"10","author":"EM Varoni","year":"2021","unstructured":"Varoni EM et al (2021) Conservative management of medication-related osteonecrosis of the jaws (MRONJ): a retrospective cohort study. Antibiotics 10(2):195","journal-title":"Antibiotics"},{"key":"8388_CR17","doi-asserted-by":"crossref","unstructured":"Meli\u00e1n Rivas AN, Rojas Donaire JA (2021) Conservative treatment of refractory medication-related osteonecrosis of the jaw using the PENTO protocol: a case report.\u00a0Odontoestomatolog\u00eda 23(38):e406","DOI":"10.22592\/ode2021n37e406"},{"issue":"1","key":"8388_CR18","doi-asserted-by":"publisher","first-page":"19","DOI":"10.5125\/jkaoms.2020.46.1.19","volume":"46","author":"MH Seo","year":"2020","unstructured":"Seo MH et al (2020) The effects of pentoxifylline and tocopherol in jaw osteomyelitis. J Korean Assoc Oral Maxillofac Surg 46(1):19\u201327","journal-title":"J Korean Assoc Oral Maxillofac Surg"},{"issue":"4","key":"8388_CR19","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/j.oooo.2016.06.019","volume":"122","author":"AA Owosho","year":"2016","unstructured":"Owosho AA et al (2016) Pentoxifylline and tocopherol in the management of cancer patients with medication-related osteonecrosis of the jaw: an observational retrospective study of initial case series. Oral Surg Oral Med Oral Pathol Oral Radiol 122(4):455\u2013459","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"issue":"2","key":"8388_CR20","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.joms.2013.06.188","volume":"72","author":"M Magremanne","year":"2014","unstructured":"Magremanne M, Reychler H (2014) Pentoxifylline and tocopherol in the treatment of yearly zoledronic acid-related osteonecrosis of the jaw in a corticosteroid-induced osteoporosis. J Oral Maxillofac Surg 72(2):334\u2013337","journal-title":"J Oral Maxillofac Surg"},{"key":"8388_CR21","doi-asserted-by":"crossref","unstructured":"Nica DF et al (2021) Complementarity of photo-biomodulation, surgical treatment, and antibiotherapy for medication-related osteonecrosis of the jaws (MRONJ). Medicina (Kaunas) 57(2):145","DOI":"10.3390\/medicina57020145"},{"issue":"6","key":"8388_CR22","doi-asserted-by":"publisher","first-page":"e626","DOI":"10.4317\/jced.58323","volume":"13","author":"L Monteiro","year":"2021","unstructured":"Monteiro L et al (2021) Photobiomodulation laser therapy in a Lenvatinib-related osteonecrosis of the jaw: a case report. J Clin Exp Dent 13(6):e626\u2013e629","journal-title":"J Clin Exp Dent"},{"issue":"4","key":"8388_CR23","doi-asserted-by":"publisher","first-page":"497","DOI":"10.34172\/jlms.2020.78","volume":"11","author":"AA Torres","year":"2020","unstructured":"Torres AA et al (2020) Medication-related osteonecrosis of the jaw and low-level laser therapy as adjuvant treatment: a case report. J Lasers Med Sci 11(4):497\u2013499","journal-title":"J Lasers Med Sci"},{"issue":"8","key":"8388_CR24","doi-asserted-by":"publisher","first-page":"e771","DOI":"10.4317\/jced.56837","volume":"12","author":"O \u015eahin","year":"2020","unstructured":"\u015eahin O et al (2020) Prevention of medication related osteonecrosis of the jaw after dentoalveolar surgery: an institution\u2019s experience. J Clin Exp Dent 12(8):e771\u2013e776","journal-title":"J Clin Exp Dent"},{"issue":"1","key":"8388_CR25","doi-asserted-by":"publisher","first-page":"98","DOI":"10.15171\/jlms.2020.16","volume":"11","author":"M Del Pilar Rodr\u00edguez-S\u00e1nchez","year":"2020","unstructured":"Del Pilar Rodr\u00edguez-S\u00e1nchez M et al (2020) The effectiveness of the low-level laser, antibiotic and surgical therapy in the treatment of medication-related osteonecrosis of the jaws: a case report. J Lasers Med Sci 11(1):98\u2013103","journal-title":"J Lasers Med Sci"},{"key":"8388_CR26","doi-asserted-by":"crossref","unstructured":"Tenore G et al (2020) Management of medication-related osteonecrosis of the jaw (MRONJ) using leukocyte- and platelet-rich fibrin (L-PRF) and photobiomodulation: a retrospective study. J Clin Med 9(11):3505","DOI":"10.3390\/jcm9113505"},{"key":"8388_CR27","doi-asserted-by":"crossref","unstructured":"Javelot MJ et al (2020) Rituximab as a trigger factor of medication-related osteonecrosis of the jaw. A case report. J Stomatol Oral Maxillofac Surg 121(3):300\u2013304","DOI":"10.1016\/j.jormas.2019.06.009"},{"issue":"2","key":"8388_CR28","doi-asserted-by":"publisher","first-page":"92","DOI":"10.15171\/jlms.2018.19","volume":"9","author":"E Merigo","year":"2018","unstructured":"Merigo E et al (2018) Combined approach to treat medication-related osteonecrosis of the jaws. J Lasers Med Sci 9(2):92\u2013100","journal-title":"J Lasers Med Sci"},{"issue":"1\u20132","key":"8388_CR29","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1111\/odi.12764","volume":"24","author":"G Favia","year":"2018","unstructured":"Favia G et al (2018) Medication-related osteonecrosis of the jaw: surgical or non-surgical treatment? Oral Dis 24(1\u20132):238\u2013242","journal-title":"Oral Dis"},{"key":"8388_CR30","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1007\/s00784-014-1384-1","volume":"19","author":"P Rugani","year":"2015","unstructured":"Rugani P et al (2015) Stage-related treatment concept of medication-related osteonecrosis of the jaw\u2014a case series. Clin Oral Invest 19:1329\u20131338","journal-title":"Clin Oral Invest"},{"issue":"8","key":"8388_CR31","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1089\/pho.2014.3742","volume":"32","author":"MA Altay","year":"2014","unstructured":"Altay MA et al (2014) Low-level laser therapy supported surgical treatment of bisphosphonate related osteonecrosis of jaws: a retrospective analysis of 11 cases. Photomed Laser Surg 32(8):468\u2013475","journal-title":"Photomed Laser Surg"},{"issue":"2","key":"8388_CR32","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1097\/SCS.0000000000008887","volume":"34","author":"MC Silva","year":"2023","unstructured":"Silva MC et al (2023) Antimicrobian photodynamic therapy in medication-related osteonecrosis of the jaws. J. Craniofac. Surg 34(2):839\u2013840","journal-title":"J. Craniofac. Surg"},{"key":"8388_CR33","doi-asserted-by":"crossref","unstructured":"Paiva AB et al (2022) Antimicrobial photodynamic and photobiomodulation adjuvant therapies for medication-related osteonecrosis of the jaw\u2013report of two cases with long-term follow-up. Clinical and Laboratorial Research in Dentistry","DOI":"10.11606\/issn.2357-8041.clrd.2022.194433"},{"key":"8388_CR34","doi-asserted-by":"publisher","first-page":"102947","DOI":"10.1016\/j.pdpdt.2022.102947","volume":"39","author":"JL Schussel","year":"2022","unstructured":"Schussel JL et al (2022) Antimicrobial photodynamic therapy as a treatment option for inoperable cases of medication-related Osteonecrosis of the jaws. Photodiagn Photodyn Ther 39:102947","journal-title":"Photodiagn Photodyn Ther"},{"key":"8388_CR35","doi-asserted-by":"crossref","unstructured":"Vigan\u00f2 R et al (2021) BPFC pure growth factor, PDT and LLLT for the treatment of severe MRONJ non-responsive to prolonged antibiotic therapy. Qeios","DOI":"10.32388\/43BHBE.2"},{"key":"8388_CR36","doi-asserted-by":"publisher","first-page":"e12","DOI":"10.34172\/jlms.2021.12","volume":"12","author":"M Almeida","year":"2021","unstructured":"Almeida M et al (2021) Photodynamic therapy as an adjunct in the treatment of medication-related osteonecrosis of the jaw: a case report. J Lasers Med Sci 12:e12","journal-title":"J Lasers Med Sci"},{"key":"8388_CR37","doi-asserted-by":"publisher","first-page":"101651","DOI":"10.1016\/j.pdpdt.2020.101651","volume":"29","author":"NC Tartaroti","year":"2020","unstructured":"Tartaroti NC et al (2020) Antimicrobial photodynamic and photobiomodulation adjuvant therapies for prevention and treatment of medication-related osteonecrosis of the jaws: case series and long-term follow-up. Photodiagnosis Photodyn Ther 29:101651","journal-title":"Photodiagnosis Photodyn Ther"},{"key":"8388_CR38","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.pdpdt.2019.05.037","volume":"27","author":"PP Poli","year":"2019","unstructured":"Poli PP et al (2019) Adjunctive application of antimicrobial photodynamic therapy in the prevention of medication-related osteonecrosis of the jaw following dentoalveolar surgery: a case series. Photodiagn Photodyn Ther 27:117\u2013123","journal-title":"Photodiagn Photodyn Ther"},{"issue":"12","key":"8388_CR39","doi-asserted-by":"publisher","first-page":"824","DOI":"10.4236\/ijcm.2016.712089","volume":"7","author":"MS Israel","year":"2016","unstructured":"Israel MS et al (2016) Photodynamic therapy for medication-related osteonecrosis of the jaws: a case report. Int J Clin Med 7(12):824\u2013828","journal-title":"Int J Clin Med"},{"key":"8388_CR40","doi-asserted-by":"crossref","unstructured":"Minamisako MC et al (2016) Medication-related osteonecrosis of jaws: a low-level laser therapy and antimicrobial photodynamic therapy case approach. Case Reports Dentist 2016:6267406","DOI":"10.1155\/2016\/6267406"},{"key":"8388_CR41","doi-asserted-by":"crossref","unstructured":"Lin LJ et al (2020) Management of stage 0 medication-related osteonecrosis of the jaw with hyperbaric oxygen therapy: a case report and review of the literature. Undersea Hyperb Med 47(2):241\u2013251","DOI":"10.22462\/04.06.2020.10"},{"issue":"1","key":"8388_CR42","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/s10266-013-0129-y","volume":"103","author":"CN Fatema","year":"2015","unstructured":"Fatema CN et al (2015) FDG-PET may predict the effectiveness of hyperbaric oxygen therapy in a patient with bisphosphonate-related osteonecrosis of the jaw: report of a case. Odontology 103(1):105\u2013108","journal-title":"Odontology"},{"issue":"1","key":"8388_CR43","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1177\/082585971302900109","volume":"29","author":"KH Al-Zoman","year":"2013","unstructured":"Al-Zoman KH et al (2013) Surgical management of bisphosphonate-related osteonecrosis of the jaw: report of three cases. J Palliat Care 29(1):52\u201357","journal-title":"J Palliat Care"},{"issue":"4","key":"8388_CR44","doi-asserted-by":"publisher","first-page":"97","DOI":"10.3390\/inventions7040097","volume":"7","author":"G Porcaro","year":"2022","unstructured":"Porcaro G et al (2022) Treatment of medication-related osteonecrosis of the jaw (MRONJ) with Er: YaG laser and ozone therapy: a case series. Inventions 7(4):97","journal-title":"Inventions"},{"key":"8388_CR45","doi-asserted-by":"crossref","unstructured":"Di Fede O et al (2022) Ozone infiltration for osteonecrosis of the jaw therapy: a case series. J Clin Med 11(18):5307","DOI":"10.3390\/jcm11185307"},{"issue":"5","key":"8388_CR46","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1111\/odi.13294","volume":"26","author":"O Nicolatou-Galitis","year":"2020","unstructured":"Nicolatou-Galitis O et al (2020) Alveolar bone histological necrosis observed prior to extractions in patients, who received bone-targeting agents. Oral Dis 26(5):955\u2013966","journal-title":"Oral Dis"},{"issue":"17","key":"8388_CR47","first-page":"9094","volume":"24","author":"F Goker","year":"2020","unstructured":"Goker F et al (2020) Treatment of BRONJ with ozone\/oxygen therapy and debridement with piezoelectric surgery. Eur Rev Med Pharmacol Sci 24(17):9094\u20139103","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"1","key":"8388_CR48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40729-019-0188-0","volume":"5","author":"G Maluf","year":"2019","unstructured":"Maluf G et al (2019) A rare case of bevacizumab-related osteonecrosis of the jaw associated with dental implants. International Journal of Implant Dentistry 5(1):1\u20136","journal-title":"International Journal of Implant Dentistry"},{"issue":"1\u20132","key":"8388_CR49","first-page":"35","volume":"63","author":"M Brozoski","year":"2014","unstructured":"Brozoski M et al (2014) Adjuvant aqueous ozone in the treatment of bisphosphonate induced necrosis of the jaws: report of two cases and long-term follow-up. Minerva Stomatol 63(1\u20132):35\u201341","journal-title":"Minerva Stomatol"},{"issue":"12","key":"8388_CR50","first-page":"1741","volume":"16","author":"A Agrillo","year":"2012","unstructured":"Agrillo A et al (2012) Bisphosphonate-related osteonecrosis of the jaw (BRONJ): 5 year experience in the treatment of 131 cases with ozone therapy. Eur Rev Med Pharmacol Sci 16(12):1741\u20131747","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"2","key":"8388_CR51","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.radonc.2004.08.021","volume":"73","author":"S Delanian","year":"2004","unstructured":"Delanian S, Lefaix JL (2004) The radiation-induced fibroatrophic process: therapeutic perspective via the antioxidant pathway. Radiother Oncol 73(2):119\u2013131","journal-title":"Radiother Oncol"},{"issue":"6","key":"8388_CR52","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.anorl.2013.11.006","volume":"131","author":"L Robard","year":"2014","unstructured":"Robard L et al (2014) Medical treatment of osteoradionecrosis of the mandible by PENTOCLO: preliminary results. Eur Ann Otorhinolaryngol Head Neck Dis 131(6):333\u2013338","journal-title":"Eur Ann Otorhinolaryngol Head Neck Dis"},{"issue":"5","key":"8388_CR53","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.oooo.2018.02.004","volume":"125","author":"M Martos-Fern\u00e1ndez","year":"2018","unstructured":"Martos-Fern\u00e1ndez M et al (2018) Pentoxifylline, tocopherol, and clodronate for the treatment of mandibular osteoradionecrosis: a systematic review. Oral Surg Oral Med Oral Pathol Oral Radiol 125(5):431\u2013439","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"8388_CR54","doi-asserted-by":"publisher","first-page":"105397","DOI":"10.1016\/j.archoralbio.2022.105397","volume":"137","author":"G Delfrate","year":"2022","unstructured":"Delfrate G et al (2022) Effect of pentoxifylline and \u03b1-tocopherol on medication-related osteonecrosis of the jaw in rats: before and after dental extraction. Arch Oral Biol 137:105397","journal-title":"Arch Oral Biol"},{"issue":"5","key":"8388_CR55","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/j.tripleo.2010.05.067","volume":"110","author":"MS Epstein","year":"2010","unstructured":"Epstein MS et al (2010) Management of bisphosphonate-associated osteonecrosis: pentoxifylline and tocopherol in addition to antimicrobial therapy. An Initial Case Series Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 110(5):593\u20136","journal-title":"An Initial Case Series Oral Surg Oral Med Oral Pathol Oral Radiol Endod."},{"issue":"5","key":"8388_CR56","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.oooo.2019.08.004","volume":"128","author":"JJ Heifetz-Li","year":"2019","unstructured":"Heifetz-Li JJ et al (2019) Systematic review of the use of pentoxifylline and tocopherol for the treatment of medication-related osteonecrosis of the jaw. Oral Surg Oral Med Oral Pathol Oral Radiol 128(5):491-497.e2","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"issue":"11","key":"8388_CR57","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1016\/j.jcms.2020.09.008","volume":"48","author":"RC Cavalcante","year":"2020","unstructured":"Cavalcante RC, Tomasetti G (2020) Pentoxifylline and tocopherol protocol to treat medication-related osteonecrosis of the jaw: a systematic literature review. J Craniomaxillofac Surg 48(11):1080\u20131086","journal-title":"J Craniomaxillofac Surg"},{"issue":"25","key":"8388_CR58","doi-asserted-by":"publisher","first-page":"2396","DOI":"10.1056\/NEJMoa1005361","volume":"363","author":"JD Bashutski","year":"2010","unstructured":"Bashutski JD et al (2010) Teriparatide and osseous regeneration in the oral cavity. N Engl J Med 363(25):2396\u20132405","journal-title":"N Engl J Med"},{"issue":"2","key":"8388_CR59","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1902\/cap.2012.110043","volume":"2","author":"JD Bashutski","year":"2012","unstructured":"Bashutski JD et al (2012) Systemic teriparatide administration promotes osseous regeneration of an intrabony defect: a case report. Clin Adv Periodontics 2(2):66\u201371","journal-title":"Clin Adv Periodontics"},{"issue":"11","key":"8388_CR60","doi-asserted-by":"publisher","first-page":"2721","DOI":"10.1007\/s00198-011-1882-9","volume":"23","author":"YD Kwon","year":"2012","unstructured":"Kwon YD et al (2012) Short-term teriparatide therapy as an adjunctive modality for bisphosphonate-related osteonecrosis of the jaws. Osteoporos Int 23(11):2721\u20132725","journal-title":"Osteoporos Int"},{"issue":"5","key":"8388_CR61","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1007\/s00198-014-2622-8","volume":"25","author":"KM Kim","year":"2014","unstructured":"Kim KM et al (2014) Distinctive role of 6-month teriparatide treatment on intractable bisphosphonate-related osteonecrosis of the jaw. Osteoporos Int 25(5):1625\u20131632","journal-title":"Osteoporos Int"},{"issue":"12","key":"8388_CR62","doi-asserted-by":"publisher","first-page":"2445","DOI":"10.1002\/jbmr.3237","volume":"32","author":"J Jung","year":"2017","unstructured":"Jung J et al (2017) Short-term teriparatide and recombinant human bone morphogenetic protein-2 for regenerative approach to medication-related osteonecrosis of the jaw: a preliminary study. J Bone Miner Res 32(12):2445\u20132452","journal-title":"J Bone Miner Res"},{"issue":"8","key":"8388_CR63","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/j.jcms.2021.02.023","volume":"49","author":"J Jung","year":"2021","unstructured":"Jung J et al (2021) Effect and timing of parathyroid hormone analog administration for preventing medication-related osteonecrosis of the jaws in a murine model. J Craniomaxillofac Surg 49(8):719\u2013725","journal-title":"J Craniomaxillofac Surg"},{"issue":"1","key":"8388_CR64","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1038\/s41598-020-79787-w","volume":"11","author":"JY Kim","year":"2021","unstructured":"Kim JY et al (2021) Effects of pre-extraction intermittent PTH administration on extraction socket healing in bisphosphonate administered ovariectomized rats. Sci Rep 11(1):54","journal-title":"Sci Rep"},{"issue":"26","key":"8388_CR65","doi-asserted-by":"publisher","first-page":"2971","DOI":"10.1200\/JCO.19.02192","volume":"38","author":"IW Sim","year":"2020","unstructured":"Sim IW et al (2020) Teriparatide promotes bone healing in medication-related osteonecrosis of the jaw: a placebo-controlled, randomized trial. J Clin Oncol 38(26):2971\u20132980","journal-title":"J Clin Oncol"},{"issue":"3","key":"8388_CR66","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1007\/s00198-019-05199-w","volume":"31","author":"Y Ohbayashi","year":"2020","unstructured":"Ohbayashi Y et al (2020) A comparative effectiveness pilot study of teriparatide for medication-related osteonecrosis of the jaw: daily versus weekly administration. Osteoporos Int 31(3):577\u2013585","journal-title":"Osteoporos Int"},{"key":"8388_CR67","doi-asserted-by":"crossref","unstructured":"Kim KM et al (2023) Effects of daily versus weekly teriparatide for medication-related osteonecrosis of the jaw: a case\u2013control study.\u00a0Oral Dis 00:1\u201310","DOI":"10.1111\/odi.14801"},{"issue":"7","key":"8388_CR68","doi-asserted-by":"publisher","first-page":"2799","DOI":"10.1111\/odi.14449","volume":"29","author":"A Tempesta","year":"2023","unstructured":"Tempesta A et al (2023) Medication-related osteonecrosis of the jaw triggered by endodontic failure in oncologic patients. Oral Dis 29(7):2799\u20132805","journal-title":"Oral Dis"},{"issue":"2","key":"8388_CR69","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1902\/jop.2013.130017","volume":"85","author":"V Thumbigere-Math","year":"2014","unstructured":"Thumbigere-Math V et al (2014) Periodontal disease as a risk factor for bisphosphonate-related osteonecrosis of the jaw. J Periodontol 85(2):226\u2013233","journal-title":"J Periodontol"},{"issue":"3","key":"8388_CR70","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1007\/s00774-020-01174-2","volume":"39","author":"T Soma","year":"2021","unstructured":"Soma T et al (2021) Tooth extraction in mice administered zoledronate increases inflammatory cytokine levels and promotes osteonecrosis of the jaw. J Bone Miner Metab 39(3):372\u2013384","journal-title":"J Bone Miner Metab"},{"issue":"10","key":"8388_CR71","doi-asserted-by":"publisher","first-page":"2318","DOI":"10.1016\/j.ajpath.2018.06.019","volume":"188","author":"T Kim","year":"2018","unstructured":"Kim T et al (2018) Removal of pre-existing periodontal inflammatory condition before tooth extraction ameliorates medication-related osteonecrosis of the jaw-like lesion in mice. Am J Pathol 188(10):2318\u20132327","journal-title":"Am J Pathol"},{"issue":"1","key":"8388_CR72","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1186\/s13287-019-1308-8","volume":"10","author":"S Kuroshima","year":"2019","unstructured":"Kuroshima S et al (2019) Systemic administration of quality- and quantity-controlled PBMNCs reduces bisphosphonate-related osteonecrosis of jaw-like lesions in mice. Stem Cell Res Ther 10(1):209","journal-title":"Stem Cell Res Ther"},{"issue":"6","key":"8388_CR73","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1016\/j.tripleo.2011.07.004","volume":"112","author":"F Moretti","year":"2011","unstructured":"Moretti F et al (2011) A prospective clinical trial for assessing the efficacy of a minimally invasive protocol in patients with bisphosphonate-associated osteonecrosis of the jaws. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 112(6):777\u2013782","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"issue":"1","key":"8388_CR74","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1080\/14756366.2018.1485149","volume":"33","author":"G Bosco","year":"2018","unstructured":"Bosco G et al (2018) Hyperbaric oxygen therapy ameliorates osteonecrosis in patients by modulating inflammation and oxidative stress. J Enzyme Inhib Med Chem 33(1):1501\u20131505","journal-title":"J Enzyme Inhib Med Chem"},{"issue":"3","key":"8388_CR75","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1152\/japplphysiol.91004.2008","volume":"106","author":"SR Thom","year":"2009","unstructured":"Thom SR (2009) Oxidative stress is fundamental to hyperbaric oxygen therapy. J Appl Physiol 106(3):988\u2013995","journal-title":"J Appl Physiol"},{"issue":"1","key":"8388_CR76","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1080\/14756366.2017.1302440","volume":"32","author":"G Vezzani","year":"2017","unstructured":"Vezzani G et al (2017) Hyperbaric oxygen therapy modulates serum OPG\/RANKL in femoral head necrosis patients. J Enzyme Inhib Med Chem 32(1):707\u2013711","journal-title":"J Enzyme Inhib Med Chem"},{"issue":"4","key":"8388_CR77","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1002\/jor.22805","volume":"33","author":"J Grassmann","year":"2015","unstructured":"Grassmann J et al (2015) Hyperbaric oxygen therapy improves angiogenesis and bone formation in critical sized diaphyseal defects. J Orthop Res 33(4):513\u2013520","journal-title":"J Orthop Res"},{"issue":"7","key":"8388_CR78","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1016\/j.joms.2012.04.001","volume":"70","author":"JJ Freiberger","year":"2012","unstructured":"Freiberger JJ et al (2012) What is the role of hyperbaric oxygen in the management of bisphosphonate-related osteonecrosis of the jaw: a randomized controlled trial of hyperbaric oxygen as an adjunct to surgery and antibiotics. J Oral Maxillofac Surg 70(7):1573\u20131583","journal-title":"J Oral Maxillofac Surg"},{"key":"8388_CR79","doi-asserted-by":"crossref","unstructured":"Beth-Tasdogan NH et al (2022) Interventions for managing medication-related osteonecrosis of the jaw. Cochr Database Syst Rev 7(7):CD012432","DOI":"10.1002\/14651858.CD012432.pub3"},{"issue":"6","key":"8388_CR80","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1097\/01.scs.0000249350.59096.d0","volume":"17","author":"A Agrillo","year":"2006","unstructured":"Agrillo A et al (2006) New therapeutic protocol in the treatment of avascular necrosis of the jaws. J Craniofac Surg 17(6):1080\u20131083","journal-title":"J Craniofac Surg"},{"key":"8388_CR81","doi-asserted-by":"crossref","unstructured":"Daigo Y et al (2020) Wound healing and cell dynamics including mesenchymal and dental pulp stem cells induced by photobiomodulation therapy: an example of socket-preserving effects after tooth extraction in rats and a literature review. Int J Mol Sci 21(18):6850","DOI":"10.3390\/ijms21186850"},{"issue":"11","key":"8388_CR82","first-page":"673","volume":"38","author":"CPF Forte","year":"2020","unstructured":"Forte CPF et al (2020) Photobiomodulation therapy reduces the inflammatory process without inhibiting bone deposition in rats in an extraction model. Photobiomodul Photomed Laser Surg 38(11):673\u2013678","journal-title":"Photobiomodul Photomed Laser Surg"},{"issue":"5","key":"8388_CR83","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1007\/s43630-021-00047-5","volume":"20","author":"SA Mohamad","year":"2021","unstructured":"Mohamad SA et al (2021) Photobiomodulation of mineralisation in mesenchymal stem cells. Photochem Photobiol Sci 20(5):699\u2013714","journal-title":"Photochem Photobiol Sci"},{"issue":"4","key":"8388_CR84","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1007\/s10103-018-2641-3","volume":"34","author":"S Kulkarni","year":"2019","unstructured":"Kulkarni S, Meer M, George R (2019) Efficacy of photobiomodulation on accelerating bone healing after tooth extraction: a systematic review. Lasers Med Sci 34(4):685\u2013692","journal-title":"Lasers Med Sci"},{"issue":"11","key":"8388_CR85","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.1016\/j.injury.2019.09.031","volume":"50","author":"JSB Escudero","year":"2019","unstructured":"Escudero JSB et al (2019) Photobiomodulation therapy (PBMT) in bone repair: a systematic review. Injury 50(11):1853\u20131867","journal-title":"Injury"},{"issue":"7","key":"8388_CR86","first-page":"440","volume":"40","author":"CCA Lopes","year":"2022","unstructured":"Lopes CCA et al (2022) Effectiveness of photobiomodulation therapy on human bone healing in dentistry: a systematic review. Photobiomodul Photomed Laser Surg 40(7):440\u2013453","journal-title":"Photobiomodul Photomed Laser Surg"},{"issue":"3","key":"8388_CR87","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1007\/s10103-019-02779-4","volume":"35","author":"FCJ Neto","year":"2020","unstructured":"Neto FCJ et al (2020) Effects of photobiomodulation in the treatment of fractures: a systematic review and meta-analysis of randomized clinical trials. Lasers Med Sci 35(3):513\u2013522","journal-title":"Lasers Med Sci"},{"issue":"5","key":"8388_CR88","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1089\/pho.2011.3219","volume":"30","author":"MG da Guarda","year":"2012","unstructured":"da Guarda MG et al (2012) Laser GaAlAs (\u03bb860 nm) photobiomodulation for the treatment of bisphosphonate-induced osteonecrosis of the jaw. Photomed Laser Surg 30(5):293\u2013297","journal-title":"Photomed Laser Surg"},{"issue":"2","key":"8388_CR89","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/s10006-020-00831-0","volume":"24","author":"GAC Momesso","year":"2020","unstructured":"Momesso GAC et al (2020) Laser surgery in management of medication-related osteonecrosis of the jaws: a meta-analysis. Oral Maxillofac Surg 24(2):133\u2013144","journal-title":"Oral Maxillofac Surg"},{"key":"8388_CR90","doi-asserted-by":"publisher","first-page":"101959","DOI":"10.1016\/j.pdpdt.2020.101959","volume":"31","author":"IA Magalh\u00e3es","year":"2020","unstructured":"Magalh\u00e3es IA et al (2020) Photobiomodulation and antimicrobial photodynamic therapy as adjunct in the treatment and prevention of osteoradionecrosis of the jaws: a case report. Photodiagnosis Photodyn Ther 31:101959","journal-title":"Photodiagnosis Photodyn Ther"},{"issue":"8","key":"8388_CR91","doi-asserted-by":"publisher","first-page":"1847","DOI":"10.1007\/s10103-017-2286-7","volume":"32","author":"GB Ate\u015f","year":"2017","unstructured":"Ate\u015f GB et al (2017) Methylene blue mediated photobiomodulation on human osteoblast cells. Lasers Med Sci 32(8):1847\u20131855","journal-title":"Lasers Med Sci"},{"key":"8388_CR92","doi-asserted-by":"publisher","first-page":"e5","DOI":"10.34172\/jlms.2022.05","volume":"13","author":"NA Jadah","year":"2022","unstructured":"Jadah NA, Shamkhi IA, Shamkhi JA (2022) Photobiomodulation and antimicrobial photodynamic influence of a 650 nm wavelength on staphylocoagulase and viability of Staphylococcus aurous. J Lasers Med Sci 13:e5","journal-title":"J Lasers Med Sci"},{"key":"8388_CR93","doi-asserted-by":"publisher","first-page":"101659","DOI":"10.1016\/j.pdpdt.2020.101659","volume":"29","author":"A Alqerban","year":"2020","unstructured":"Alqerban A (2020) Efficacy of antimicrobial photodynamic and photobiomodulation therapy against Treponema denticola, fusobacterium nucleatum and human beta defensin-2 levels in patients with gingivitis undergoing fixed orthodontic treatment: A clinic-laboratory study. Photodiagnosis Photodyn Ther 29:101659","journal-title":"Photodiagnosis Photodyn Ther"},{"key":"8388_CR94","doi-asserted-by":"publisher","first-page":"102889","DOI":"10.1016\/j.pdpdt.2022.102889","volume":"38","author":"PGB Silva","year":"2022","unstructured":"Silva PGB et al (2022) Photodynamic therapy and photobiomodulation therapy in zoledronic acid-induced osteonecrosis in rats. Photodiagnosis Photodyn Ther 38:102889","journal-title":"Photodiagnosis Photodyn Ther"},{"key":"8388_CR95","doi-asserted-by":"publisher","first-page":"7365","DOI":"10.1007\/s00520-022-07127-x","volume":"9","author":"de C\u00e1ssia Dias Viana Andrade, R.,","year":"2022","unstructured":"de C\u00e1ssia Dias Viana Andrade, R., et al (2022) Comparative randomized trial study about the efficacy of photobiomodulation and curcumin antimicrobial photodynamic therapy as a coadjuvant treatment of oral mucositis in oncologic patients: antimicrobial, analgesic, and degree alteration effect. Support Care Cancer. 9:7365\u20137371","journal-title":"Support Care Cancer."},{"key":"8388_CR96","doi-asserted-by":"crossref","unstructured":"Calderipe CB et al (2024) What is the effect of lactoferrin on oral and jawbone tissue repair? A systematic review. Brit J Oral Maxillofacial Surg 62(1):4\u201314","DOI":"10.1016\/j.bjoms.2023.10.019"},{"issue":"1","key":"8388_CR97","doi-asserted-by":"publisher","first-page":"58","DOI":"10.3390\/pharmaceutics13010058","volume":"13","author":"E Agatieva","year":"2021","unstructured":"Agatieva E et al (2021) Evaluation of direct and cell-mediated lactoferrin gene therapy for the maxillofacial area abscesses in rats. Pharmaceutics 13(1):58","journal-title":"Pharmaceutics"},{"issue":"1","key":"8388_CR98","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1111\/odi.13989","volume":"29","author":"X Xiao","year":"2023","unstructured":"Xiao X et al (2023) Gavage-administered lactoferrin promotes palatal expansion stability in a dose-dependent manner. Oral Dis 29(1):254\u2013264","journal-title":"Oral Dis"},{"issue":"3","key":"8388_CR99","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1007\/s10534-018-0081-y","volume":"31","author":"F Calvani","year":"2018","unstructured":"Calvani F et al (2018) Efficacy of bovine lactoferrin in the post-surgical treatment of patients suffering from bisphosphonate-related osteonecrosis of the jaws: an open-label study. Biometals 31(3):445\u2013455","journal-title":"Biometals"},{"key":"8388_CR100","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.ebiom.2017.04.017","volume":"19","author":"Z Yang","year":"2017","unstructured":"Yang Z et al (2017) Fluvastatin prevents lung adenocarcinoma bone metastasis by triggering autophagy. EBioMedicine 19:49\u201359","journal-title":"EBioMedicine"},{"issue":"6","key":"8388_CR101","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1007\/s10096-018-3227-5","volume":"37","author":"HHT Ko","year":"2018","unstructured":"Ko HHT et al (2018) In vitro antibacterial effects of statins against bacterial pathogens causing skin infections. Eur J Clin Microbiol Infect Dis 37(6):1125\u20131135","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"1","key":"8388_CR102","doi-asserted-by":"publisher","first-page":"015001","DOI":"10.1088\/1748-6041\/11\/1\/015001","volume":"11","author":"N Yasunami","year":"2015","unstructured":"Yasunami N et al (2015) Acceleration of hard and soft tissue healing in the oral cavity by a single transmucosal injection of fluvastatin-impregnated poly (lactic-co-glycolic acid) microspheres An in vitro and rodent in vivo study. Biomed Mater 11(1):015001","journal-title":"Biomed Mater"},{"issue":"1","key":"8388_CR103","doi-asserted-by":"publisher","first-page":"5620","DOI":"10.1038\/s41598-020-61724-6","volume":"10","author":"N Adachi","year":"2020","unstructured":"Adachi N et al (2020) Preventive effect of fluvastatin on the development of medication-related osteonecrosis of the jaw. Sci Rep 10(1):5620","journal-title":"Sci Rep"},{"issue":"6","key":"8388_CR104","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1002\/JPER.21-0294","volume":"93","author":"K Sanda","year":"2022","unstructured":"Sanda K et al (2022) Therapeutic effect of fluvastatin on medication-related osteonecrosis of the jaw. J Periodontol 93(6):837\u2013846","journal-title":"J Periodontol"},{"issue":"4","key":"8388_CR105","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1016\/j.bone.2010.12.003","volume":"48","author":"WG Jang","year":"2011","unstructured":"Jang WG et al (2011) Metformin induces osteoblast differentiation via orphan nuclear receptor SHP-mediated transactivation of Runx2. Bone 48(4):885\u2013893","journal-title":"Bone"},{"issue":"6","key":"8388_CR106","doi-asserted-by":"publisher","first-page":"4727","DOI":"10.18632\/aging.102796","volume":"12","author":"SH Park","year":"2020","unstructured":"Park SH et al (2020) Metformin coordinates osteoblast\/osteoclast differentiation associated with ischemic osteonecrosis. Aging (Albany NY) 12(6):4727\u20134741","journal-title":"Aging (Albany NY)"},{"key":"8388_CR107","doi-asserted-by":"publisher","first-page":"108875","DOI":"10.1016\/j.biopha.2019.108875","volume":"115","author":"K Chen","year":"2019","unstructured":"Chen K et al (2019) Metformin inhibits the proliferation of rheumatoid arthritis fibroblast-like synoviocytes through IGF-IR\/PI3K\/AKT\/m-TOR pathway. Biomed Pharmacother 115:108875","journal-title":"Biomed Pharmacother"},{"key":"8388_CR108","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1016\/j.omtm.2020.05.008","volume":"17","author":"Y Chen","year":"2020","unstructured":"Chen Y et al (2020) Metformin, an AMPK activator, inhibits activation of FLSs but promotes HAPLN1 secretion. Mol Ther Methods Clin Dev 17:1202\u20131214","journal-title":"Mol Ther Methods Clin Dev"},{"key":"8388_CR109","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.726490","volume":"12","author":"M Gharib","year":"2021","unstructured":"Gharib M et al (2021) Efficacy and safety of metformin use in rheumatoid arthritis: a randomized controlled study. Front Pharmacol 12:726490","journal-title":"Front Pharmacol"},{"issue":"2","key":"8388_CR110","doi-asserted-by":"publisher","first-page":"219","DOI":"10.2186\/jpr.JPOR_2019_629","volume":"65","author":"T Nakagawa","year":"2021","unstructured":"Nakagawa T et al (2021) Effects of metformin on the prevention of bisphosphonate-related osteonecrosis of the jaw-like lesions in rats. J Prosthodont Res 65(2):219\u2013224","journal-title":"J Prosthodont Res"},{"issue":"10","key":"8388_CR111","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1016\/j.jcms.2016.07.026","volume":"44","author":"T M\u00fccke","year":"2016","unstructured":"M\u00fccke T et al (2016) Prevention of bisphosphonate-related osteonecrosis of the jaws in patients with prostate cancer treated with zoledronic acid - a prospective study over 6 years. J Craniomaxillofac Surg 44(10):1689\u20131693","journal-title":"J Craniomaxillofac Surg"},{"issue":"2","key":"8388_CR112","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.oooo.2021.06.003","volume":"133","author":"C Ottesen","year":"2022","unstructured":"Ottesen C et al (2022) Tooth extractions in patients with cancer receiving high-dose antiresorptive medication: a randomized clinical feasibility trial of drug holiday versus drug continuation. Oral Surg Oral Med Oral Pathol Oral Radiol 133(2):165\u2013173","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"issue":"1","key":"8388_CR113","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1186\/s12903-021-01965-7","volume":"21","author":"\u00d6 \u00d6zalp","year":"2021","unstructured":"\u00d6zalp \u00d6 et al (2021) Promising results of surgical management of advanced medication related osteonecrosis of the jaws using adjunctive leukocyte and platelet rich fibrin. BMC Oral Health 21(1):613","journal-title":"BMC Oral Health"},{"issue":"8","key":"8388_CR114","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1016\/j.jcms.2016.05.004","volume":"44","author":"P Lopez-Jornet","year":"2016","unstructured":"Lopez-Jornet P et al (2016) Medication-related osteonecrosis of the jaw: is autologous platelet concentrate application effective for prevention and treatment? A systematic review J Craniomaxillofac Surg 44(8):1067\u20131072","journal-title":"A systematic review J Craniomaxillofac Surg"},{"issue":"7","key":"8388_CR115","doi-asserted-by":"publisher","first-page":"4529","DOI":"10.1007\/s00784-020-03766-8","volume":"25","author":"MO Y\u00fcce","year":"2021","unstructured":"Y\u00fcce MO, Adal\u0131 E, I\u015f\u0131k G (2021) The effect of concentrated growth factor (CGF) in the surgical treatment of medication-related osteonecrosis of the jaw (MRONJ) in osteoporosis patients: a randomized controlled study. Clin Oral Investig 25(7):4529\u20134541","journal-title":"Clin Oral Investig"},{"key":"8388_CR116","doi-asserted-by":"crossref","unstructured":"On SW et al (2021) Various therapeutic methods for the treatment of medication-related osteonecrosis of the jaw (MRONJ) and their limitations: a narrative review on new molecular and cellular therapeutic approaches. Antioxidants (Basel) 10(5):680","DOI":"10.3390\/antiox10050680"},{"issue":"7","key":"8388_CR117","doi-asserted-by":"publisher","first-page":"2165","DOI":"10.1007\/s00784-016-2004-z","volume":"21","author":"T Asaka","year":"2017","unstructured":"Asaka T et al (2017) Platelet-rich fibrin may reduce the risk of delayed recovery in tooth-extracted patients undergoing oral bisphosphonate therapy: a trial study. Clin Oral Investig 21(7):2165\u20132172","journal-title":"Clin Oral Investig"},{"issue":"1","key":"8388_CR118","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/s10561-021-09922-y","volume":"23","author":"M Ragazzo","year":"2022","unstructured":"Ragazzo M et al (2022) Human amniotic membrane: an improvement in the treatment of Medication-related osteonecrosis of the jaw (MRONJ)? A case-control study Cell Tissue Bank 23(1):129\u2013141","journal-title":"A case-control study Cell Tissue Bank"},{"issue":"3","key":"8388_CR119","first-page":"811","volume":"31","author":"F Inchingolo","year":"2017","unstructured":"Inchingolo F et al (2017) Platelet rich fibrin in the management of medication-related osteonecrosis of the jaw: a clinical and histopathological evaluation. J Biol Regul Homeost Agents 31(3):811\u2013816","journal-title":"J Biol Regul Homeost Agents"},{"issue":"6","key":"8388_CR120","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1016\/j.joms.2016.12.005","volume":"75","author":"JH Park","year":"2017","unstructured":"Park JH, Kim JW, Kim SJ (2017) Does the addition of bone morphogenetic protein 2 to platelet-rich fibrin improve healing after treatment for medication-related osteonecrosis of the jaw? J Oral Maxillofac Surg 75(6):1176\u20131184","journal-title":"J Oral Maxillofac Surg"},{"issue":"2","key":"8388_CR121","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1097\/SCS.0000000000006976","volume":"32","author":"P Ye","year":"2021","unstructured":"Ye P et al (2021) The role of autologous platelet concentrates in the treatment of medication-related osteonecrosis of the jaw. J Craniofac Surg 32(2):621\u2013625","journal-title":"J Craniofac Surg"},{"issue":"1","key":"8388_CR122","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1159\/000533821","volume":"16","author":"JB Epstein","year":"2023","unstructured":"Epstein JB et al (2023) Medication-related osteonecrosis of the jaw: successful medical management of complex maxillary alveolus with sinus involvement. Case Rep Oncol 16(1):397\u2013413","journal-title":"Case Rep Oncol"},{"issue":"8","key":"8388_CR123","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1016\/j.ijom.2019.03.894","volume":"48","author":"O Breik","year":"2019","unstructured":"Breik O et al (2019) Is there a role for pentoxifylline and tocopherol in the management of advanced osteoradionecrosis of the jaws with pathological fractures? Case reports and review of the literature. Int J Oral Maxillofac Surg 48(8):1022\u20131027","journal-title":"Int J Oral Maxillofac Surg"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-024-08388-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-024-08388-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-024-08388-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,17]],"date-time":"2024-04-17T04:10:08Z","timestamp":1713327008000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00520-024-08388-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,5]]},"references-count":123,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["8388"],"URL":"https:\/\/doi.org\/10.1007\/s00520-024-08388-4","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,5]]},"assertion":[{"value":"30 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The systematic review is not subject to ethical review.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors have no competing interests to declare.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"212"}}